Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M--Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M--ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IHE

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IHE is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IHE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bunka, ChristopherDirector, Senior Officer 2015-07-24Buy5,000$0.15118986.67 view
Bunka, ChristopherDirector, Senior Officer 2015-07-24Buy10,000$0.15118986.67 view
Bunka, ChristopherDirector, Senior Officer 2015-07-24Buy20,000$0.15118986.67 view
Bunka, ChristopherDirector, Senior Officer 2015-07-24Buy10,000$0.16111543.75 view
Bunka, ChristopherDirector, Senior Officer 2015-07-24Buy25,000$0.15118986.67 view
Bunka, ChristopherDirector, Senior Officer 2015-07-24Buy5,000$0.15118986.67 view
Bunka, ChristopherDirector, Senior Officer 2015-07-24Buy5,000$0.15118986.67 view
Bunka, ChristopherDirector, Senior Officer 2015-07-24Buy5,000$0.15118986.67 view
Bunka, ChristopherDirector, Senior Officer 2015-07-24Buy20,000$0.15118986.67 view
Hajdu, AttilaSenior Officer 2015-07-24Buy12,410$0.17104976.47 view

Quarterly/Annual Reports about IHE:

    News about IHE:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Existing Home Sales Rose 3.20% in June: ITB Rose More than 2% Jul 24 2015
    The Bargain Stocks Leading The Next Trillion-Dollar Industry Jul 16 2015
    4 Healthcare ETFs to Buy as JNJ Beats Estimates - ETF News And Commentary Jul 15 2015
    M&A Activity Will Support Pharma ETFs Through Rising Rate Environment Jul 09 2015
    Healthcare ETFs: Specialized Drugs in Greater Demand Jul 07 2015
    Direxion Files Two Triple-Leveraged Pharmaceutical ETFs - ETF News And Commentary Jul 03 2015
    Investors Can Still Find Growth in Healthcare ETFs Jul 01 2015
    Healthcare ETFs can Work Even When Interest Rates Rise Jun 30 2015
    The Zacks Analyst Blog Highlights: iShares U.S. Pharmaceuticals ETF, SPDR S&P Semiconductor ETF,... Jun 11 2015
    Innovators to Support Healthcare Sector, ETFs’ Growth May 20 2015
    The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, iShares U.S. Pharmaceuticals ETF,... May 07 2015
    Can big pharma's earnings today keep market bulls engaged? Apr 27 2015
    The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals... Apr 20 2015
    A Beginner's Guide to Pharma ETFs - ETF News And Commentary Apr 17 2015
    Healthcare ETFs in Focus Post JNJ Earnings Beat - ETF News And Commentary Apr 16 2015
    Pharma ETFs Soar on Acquisition Spree - ETF News And Commentary Apr 13 2015
    Pharma ETFs Boosted by Mylan’s Giant Offer for Perrigo Apr 08 2015
    3 Small Cap Pharma Stocks Set to Surge Following Q1 Earnings - Stocks in the News Mar 31 2015
    12 Best Biotech and Health Care ETFs to Add to Your Portfolio Mar 12 2015
    Pharma ETFs to Soar No Matter Who Wins Salix - ETF News And Commentary Mar 12 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK